Access cutting-edge melanoma treatment through this clinical trial at a research site in San Francisco. Study-provided care at no cost to qualified participants.
Access melanoma specialists in San Francisco at no cost
This study follows strict safety protocols and ethical guidelines
All study-related melanoma treatment provided free
The goal of this clinical trial is to understand if a new drug called LNS8801 can safely treat patients with melanoma. The primary question to be answered is what is the average length of time during which melanoma does not grow or spread after starting treatment with LNS8801? Researchers will compare LNS8801 taken alone or LNS8801 taken together with another drug called pembrolizumab to other therapies as decided by the treating doctor. 135 patients will be randomly (like flipping a coin) plac
Sponsor: Linnaeus Therapeutics, Inc.
Check if you qualify for this melanoma clinical trial in San Francisco, CA
If you're searching for melanoma treatment options in San Francisco, CA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our San Francisco research site is actively enrolling participants for this clinical trial. You'll receive care from experienced melanoma specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.